Presentation TCT 2017 Cerebral Protection During TAVR: Routine vs Selective Use Presenter: David Hildick-Smith, Lars Sondergaard, Axel Linke October 29, 2017
News Daily News Many Stroke Patients Stop Statins or Never Start, With Dire Consequences Michael O'Riordan August 02, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2017 Shelley Wood March 01, 2017